Creative Medical Technology Holdings Inc (CELZ)
4.16
0.00 (0.00%)
USD |
NASDAQ |
Jun 14, 16:00
4.165
0.00 (0.00%)
After-Hours: 20:00
Creative Medical Technology Holdings Enterprise Value: -3.399M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | -3.399M |
| June 13, 2024 | -3.399M |
| June 12, 2024 | -3.372M |
| June 11, 2024 | -3.278M |
| June 10, 2024 | -3.278M |
| June 07, 2024 | -3.096M |
| June 06, 2024 | -3.082M |
| June 05, 2024 | -3.184M |
| June 04, 2024 | -3.143M |
| June 03, 2024 | -3.130M |
| May 31, 2024 | -3.143M |
| May 30, 2024 | -2.984M |
| May 29, 2024 | -3.143M |
| May 28, 2024 | -3.076M |
| May 24, 2024 | -3.197M |
| May 23, 2024 | -3.076M |
| May 22, 2024 | -3.069M |
| May 21, 2024 | -3.076M |
| May 20, 2024 | -3.210M |
| May 17, 2024 | -3.008M |
| May 16, 2024 | -3.156M |
| May 15, 2024 | -3.076M |
| May 14, 2024 | -3.022M |
| May 13, 2024 | -3.170M |
| May 10, 2024 | -3.143M |
| Date | Value |
|---|---|
| May 09, 2024 | -3.174M |
| May 08, 2024 | -2.998M |
| May 07, 2024 | -2.767M |
| May 06, 2024 | -2.957M |
| May 03, 2024 | -3.045M |
| May 02, 2024 | -2.835M |
| May 01, 2024 | -2.801M |
| April 30, 2024 | -2.984M |
| April 29, 2024 | -3.059M |
| April 26, 2024 | -3.147M |
| April 25, 2024 | -3.038M |
| April 24, 2024 | -2.482M |
| April 23, 2024 | -2.468M |
| April 22, 2024 | -2.455M |
| April 19, 2024 | -2.482M |
| April 18, 2024 | -2.482M |
| April 17, 2024 | -2.231M |
| April 16, 2024 | -1.953M |
| April 15, 2024 | -1.940M |
| April 12, 2024 | -1.950M |
| April 11, 2024 | -1.604M |
| April 10, 2024 | -1.428M |
| April 09, 2024 | -1.368M |
| April 08, 2024 | -1.516M |
| April 05, 2024 | -1.53M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-17.11M
Minimum
Dec 22 2022
69.86M
Maximum
Feb 10 2021
4.047M
Average
1.539M
Median
Feb 12 2020
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.382M |
| Palatin Technologies Inc | 19.39M |
| iBio Inc | 30.46M |
| Theriva Biologics Inc | -10.87M |
| Oragenics Inc | 6.996M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.042M |
| Total Expenses (Quarterly) | 1.123M |
| EPS Diluted (Quarterly) | -0.73 |
| Earnings Yield | -89.90% |
| Normalized Earnings Yield | -90.38 |